New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 7, 2013
09:08 EDTDNDNDendreon sees Q4 revenue approximately $85.5M, consensus $80.71M
Guidance includes an approximate $3.8M favorable adjustment to the company’s chargebacks reserve due to a change in estimate. On a pro-forma basis, excluding this adjustment, revenue for the quarter is expected to be approximately $81.6M, up 5% on a sequential basis.
News For DNDN From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 16, 2014
09:13 EDTDNDNNICE says Dendreon drug too expensive for prostate cancer use
Subscribe for More Information

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use